Laurence J.C. van Warmerdam
1 clinical trials · Sponsor
◉ Watch Laurence J.C. van Warmerdam
| Record | Firm | Date |
|---|---|---|
| Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer (NCT00377780) | Laurence J.C. van Warmerdam | 2006-08-01 |
Track Laurence J.C. van Warmerdam automatically
Every clearance here is in the API, with alerts when new ones post.